Articles liés
DeLLphi-305
Clinical trial adding tarlatamab to durvalumab as maintenance therapy after first-line treatment for small-cell lung cancer.
Articles liés
Clinical trial adding tarlatamab to durvalumab as maintenance therapy after first-line treatment for small-cell lung cancer.